ENDOCRYTE IPO ANALYSIS The family that I chose to conduct my IPO on is called Endocyte. Endocyte just went public in July 2011 and is currently being traded on the NASDAQ with a Global Market symbol of (ECYT). Here is a little background on Endocyte as a family as well as the industry they are in: Endocyte is a biopharmaceutical company developing rateed therapies for the treatment of cancer and rabble-rousing maladys. The company uses proprietary technology to create novel modest molecule drug conjugates, or SMDCs, and comrade imaging diagnostics. SMDCs combat-readyly target receptors that are over-expressed on pathologic cells, relative to rosy-cheeked cells. This targeted start is knowing to enable the treatment of diligents with highly active drugs at greater doses, delivered more oft, and over longer periods of time than would be possible with the untargeted drug alone. Endocyte is also developing companion imaging diagnostics for each of the SMDCs that are designed to site the patients whose disease over-expresses the target of the therapy and who are therefore more apparent to make from treatment.

This combination of an SMDC with its companion imaging diagnostic is designed to alter the treatment of patients by delivering effective therapy, selectively to diseased cells, in the patients most likely to benefit. The bakshis SMDC, EC145, targets the vitamin M receptor, which is frequently over-expressed in some of the most prevalent, and difficult to treat self-coloured tumor traces, including ovarian, non-small cell lung, breast, colorectal, kidney, endometrial and other cancers. They identify the front of the folate receptor in canc er patients by development EC20, a propriet! ary companion imaging diagnostic for EC145. Endocyte has elect platinum-resistant ovarian cancer, or PROC, a highly treatment-resistant disease, as its lead indication for development of EC145 because of the high unmet need in treating this patient macrocosm and the high percentage...If you want to get a proficient essay, frame it on our website:
OrderEssay.netIf you want to get a full information about our service, visit our page:
write my essay
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.